Literature DB >> 14720194

Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium.

Terué Ikarashi1, Hiroko Ida-Yonemochi, Kazufumi Ohshiro, Jun Cheng, Takashi Saku.   

Abstract

BACKGROUND: Intercellular deposition of perlecan, a major heparan sulfate proteoglycan (HSPG) of the basement membrane, is known to result in characteristic stellate reticulum-like structures in ameloblastomas or tooth germs. Although enlargement of the intercellular space is one of the histological characteristics of epithelial dysplasia of oral mucosa, the mode of expression of perlecan is poorly understood in these epithelial lesions.
METHODS: Eighty-two biopsy specimens consisting of normal and hyperplastic epithelium, epithelial dysplasia, and squamous cell carcinomas were examined for both perlecan core protein and heparan sulfate (HS) chains by immunohistochemistry and in situ hybridization.
RESULTS: In normal and hyperplastic epithelium, perlecan core protein and HS chains were localized in the cell border of parabasal cells and lower prickle cells, and HS chains were also found in basal cells. With an increase in the severity of epithelial dysplasia, the core protein was heavily and extensively deposited in the interepithelial space as well as in the cytoplasm of epithelial cells from the basal to the surface layers. Its gene expression was confirmed in the cells around the protein deposits. On the other hand, HS chains were enhanced in mild dysplasia, but decreased in moderate and severe dysplasias. In squamous cell carcinomas, either the core protein or HS chains were found scarcely in tumor cells but abundantly in the stromal space.
CONCLUSIONS: The findings indicate that perlecan is localized in the intercellular space of the oral epithelia, and that it is over-expressed in dysplastic epithelial cells and is deposited in their interepithelial space, which results in the histology of reduction of cellular cohesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720194     DOI: 10.1111/j.1600-0714.2004.00026.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  Intraepithelially entrapped blood vessels in oral carcinoma in-situ.

Authors:  Akinori Funayama; Satoshi Maruyama; Manabu Yamazaki; Kamal Al-Eryani; Susumu Shingaki; Chikara Saito; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2012-04-05       Impact factor: 4.064

2.  Perlecan-enriched intercellular space of junctional epithelium provides primary infrastructure for leukocyte migration through squamous epithelial cells.

Authors:  Satoshi Maruyama; Manami Itagaki; Hiroko Ida-Yonemochi; Takehiko Kubota; Manabu Yamazaki; Tatsuya Abé; Hiromasa Yoshie; Jun Cheng; Takashi Saku
Journal:  Histochem Cell Biol       Date:  2014-02-23       Impact factor: 4.304

3.  Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration.

Authors:  Toshihiko Mikami; Satoshi Maruyama; Tatsuya Abé; Takanori Kobayashi; Manabu Yamazaki; Akinori Funayama; Susumu Shingaki; Tadaharu Kobayashi; Cheng Jun; Takashi Saku
Journal:  Virchows Arch       Date:  2015-03-04       Impact factor: 4.064

4.  Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation.

Authors:  Masayuki Tsuneki; Satoshi Maruyama; Manabu Yamazaki; Ahmed Essa; Tatsuya Abé; Hamzah Ali Babkair; Md Shahidul Ahsan; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2012-12-22       Impact factor: 4.064

5.  An immunohistochemical study of basement membrane heparan sulfate proteoglycan (perlecan) in oral epithelial dysplasia and squamous cell carcinoma.

Authors:  Mithilesh Mishra; Vidyadevi Chandavarkar; Veena V Naik; Alka D Kale
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

Review 6.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

7.  Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.

Authors:  Rebeca Kawahara; Daniela C Granato; Carolina M Carnielli; Nilva K Cervigne; Carine E Oliveria; César Rivera; César A R Martinez; Sami Yokoo; Felipe P Fonseca; Marcio Lopes; Alan R Santos-Silva; Edgard Graner; Ricardo D Coletta; Adriana Franco Paes Leme
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

8.  Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.

Authors:  Yoshimasa Sumita; Manabu Yamazaki; Satoshi Maruyama; Tatsuya Abé; Jun Cheng; Ritsuo Takagi; Jun-Ichi Tanuma
Journal:  Oncol Rep       Date:  2018-08-22       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.